TYRATyra Biosciences Inc. Common Stock

NAS · US · Healthcare · Biotechnology · tyra.bio
26.05USD+1.40%Mkt Cap: 1.55B $P/E:

Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platfo…

Key Statistics

Company
Market Cap1.55B $
Enterprise Value1.18B $
Revenue (TTM)
Gross Profit
Net Income (TTM)-119.95M $
Revenue/Share
Last Price26.05 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees87
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-8.67
PEG
EV/EBITDA-7.41
EV/Revenue
P/S
P/B5.32
EPS (TTM)-2.29
EPS (Forward)-2.96
52W Range
9.96052% of range40.65
52W High40.65 USD
52W Low9.960 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-46.28%
ROA-42.44%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-95.14M $
CapEx (TTM)141.00K $
FCF Margin
FCF Yield-4.07%
Net Debt-348.36M $
Net Debt/EBITDA2.18
Balance Sheet
Debt/Equity0.02
Current Ratio14.90
Quick Ratio14.48
Book Value/Sh4.826 USD
Cash/Share5.931 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)50.82 USD
Upside (mean)+95.1%
Target Range39.00 USD59.00 USD
$39.00+95.1% to mean$59.00
# Analysts11
Ownership
Shares Out.59.47M
Float35.21M
Insiders2.85%
Institutions117.45%
Short Interest
Short Ratio15.6d
Short % Float28.56%
Short % Out.15.50%
Shares Short9.25M
Short (prev mo.)11.92M
Technical
SMA 5029.62 (-12.0%)
SMA 20029.72 (-12.3%)
Beta0.77
S&P 52W Chg18.16%
Avg Vol (30d)595.50K
Avg Vol (10d)498.30K
Technical Indicators
RSI (14)40.1
MACD-1.4193
MACD Signal-1.2791
MACD Hist.-0.1402
BB Upper34.15 USD
BB Middle28.21 USD
BB Lower22.27 USD
BB Width42.12%
ATR (14)1.604 USD
Vol Ratio (20d)0.52x